Fulgent Genetics, Inc. (FLGT)
NASDAQ: FLGT · Real-Time Price · USD
18.55
+0.02 (0.11%)
Aug 6, 2026, 4:00 PM EDT - Market closed

Fulgent Genetics Revenue

Fulgent Genetics had revenue of $85.39M in the quarter ending June 30, 2026, with 4.38% growth. This brings the company's revenue in the last twelve months to $323.93M, up 6.83% year-over-year. In the year 2025, Fulgent Genetics had annual revenue of $322.67M with 13.83% growth.

Revenue (ttm)
$323.93M
Revenue Growth
+6.83%
P/S Ratio
1.58
Revenue / Employee
$246,336
Employees
1,315
Market Cap
510.41M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2025322.67M39.20M13.83%
Dec 31, 2024283.47M-5.74M-1.99%
Dec 31, 2023289.21M-329.76M-53.27%
Dec 31, 2022618.97M-373.62M-37.64%
Dec 31, 2021992.58M570.87M135.37%
Dec 31, 2020421.71M389.18M1,196.46%
Dec 31, 201932.53M11.18M52.35%
Dec 31, 201821.35M2.62M13.99%
Dec 31, 201718.73M454.00K2.48%
Dec 31, 201618.28M8.70M90.85%
Dec 31, 20159.58M8.30M649.30%
Dec 31, 20141.28M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Related Stocks

Company NameRevenue
Myriad Genetics806.60M
NeoGenomics766.30M
OPKO Health587.90M
CareDx458.09M
GeneDx Holdings454.43M
Castle Biosciences357.28M
Biodesix96.10M
Exagen71.12M
Revenue Rankings